summari host investor meet
manag came away increas confid
compani outlook key take-away meet
includ multipl sourc potenti upsid
guidanc misight us launch track initi manag
forecast may prove conserv manag focus
increas myday suppli us market expect remain
capac constrain forese futur increas dtc
behind paragard support least stabl growth mid-
singl digit overal believ well posit deliv
possibl exceed expect rais
price target base ep
estim
see multipl sourc potenti upsid guidanc
guid ex-fx sale growth tax rate ep
includ fx benefit manag
confid deliv outlook acknowledg
sever sourc potenti upsid area possibl conservat
includ follow fx may increment
benefit total base recent currenc move misight us
launch could ramp faster canadian model thu
upsid potenti revenu capac ramp myday
could proceed faster expect reduc suppli constraint
potenti leverag freight/handl cost possibl
absenc obsolesc cost margin ep
headwind tax rate could lower
assum benefit stock option expens benefit
misight us launch track march host first
launch meet misight myopia manag track
offici launch product march manag misight sale
forecast year grow
somewhat base product uptak canada howev
note canadian launch support salesforc
us product sold contact len rather
myopia treatment plan file misight approv
japan china leverag exist clinic data releas
data misight studi expect year
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
continu previou page
us contact len price environ seem stabil competitor alc taken
price increas start year contact len portfolio evalu
littl later year addit understand overal rebat level improv somewhat
compani lower rebat amount exist wearer net-net sens net price
rel stabl slightli improv us contact len market even competitor launch
new product year
focus increas myday product capac compani plan spend
capital-expenditure major direct toward expand manufactur capac
silicon hydrogel daili product myday particular note current product line
run full capac implement price increas pull product select
european market restrict sampl help increas suppli compani put
multipl new product line take time ramp reach full capac thu
could remain capac constrain myday next coupl year scale new product
line expect somewhat pressur margin near-term manag expect capital-expenditure
declin somewhat meaning
paragard growth expect remain stabl mid-singl digit base impact dtc
market paragard select us citi compani plan spend increment
paragard promot includ tv commerci nation cabl network manag feel
paragard grow mid-singl digit go forward driven price increas
volum growth compani still see opportun grow paragard share us non-hormon
contracept market current
price target
price target base ep estim risk includ slower growth
contact len market slow misight uptak increas competit stronger dollar
particip attract contact len market sale grow
strong portfolio lens across modal help compani continu take share
global medic devic compani develop manufactur market health care
product two divis coopervis produc contact lens account
revenu coopersurg women health busi contribut nearli revenu
coopervis tie player nearli share billion global soft contact len
market revenu grew pro forma billion million
